NCT07068399 Use of Shock Wave Therapy for Neo-Vascularisation in Non-critical Coronary Artery Disease: Validation by Quantitative Cardiac MRI Perfusion
| NCT ID | NCT07068399 |
| Status | Recruiting |
| Phase | — |
| Sponsor | The University of Hong Kong |
| Condition | Coronary Artery Disease |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2020-09-01 |
| Primary Completion | 2026-01-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2020-09-01 with a primary completion date of 2026-01-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a randomised controlled trial aimed to demonstrate the effect of cardiac extracorporeal shock wave therapy (CSWT) on the angiogenesis effect of myocardium by determining myocardial perfusion and left ventricular function in patients with coronary artery disease (CAD) when measured by cardiac MRI before and after the treatment.
Eligibility Criteria
Inclusion criteria: * Patients with symptoms of coronary artery disease * Patients without obstructive coronary artery disease * with LVEF not \< 40%. Exclusion criteria: * Age \< 18 years, * Pregnancy or lactation. * Contraindication to contrast enhanced stress Cardiac Magnetic Resonance (eg. Estimated GFR \<30ml/min/1.73m2, severe allergy to gadolinium based contrast agent, contraindication to adenosine) * Life expectancy \<24 months * Haemodynamically unstable * Participation in other clinical trial within 6 months of enrollment. * Recent myocardial infarction within 6 months. * Unable to consent to or perform components of the study.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07068399 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Coronary Artery Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07068399 currently recruiting?
Yes, NCT07068399 is actively recruiting participants. Contact the research team at myng2@hku.hk for enrollment information.
Where is the NCT07068399 trial being conducted?
This trial is being conducted at Hong Kong, Hong Kong.
Who is sponsoring the NCT07068399 clinical trial?
NCT07068399 is sponsored by The University of Hong Kong. The trial plans to enroll 100 participants.